Who We Are

The team behind a world of change.

Laura Towart

Founder & CEO

Founder and former CEO of Celmatix, a NY based early stage fertility genomics, ovarian therapeutics/ women’s health company. Laura co-founded Celmatix in 2008 and it is a true pioneer in personalized genomics. Graduate of the Weill Cornell Graduate School of Medical
Sciences and Memorial Sloan Kettering Cancer Center doctoral program.

Bill Liao


Chinese-Australian entrepreneur, venture investor, diplomat, author, and speaker with a distinguished record in the areas of business, development and community activism.

Sami Mikati

Investor Director

An experienced corporate executive and angel investorin early stage UK life science startups. Sami brings a network and active commercial approach to early stage challenges.

Dr. Jennifer Levin Carter


Managing Director of JLC Precision Health Strategies, with a track record of developing innovative data-driven strategies and solutions at the intersection of healthcare IT and services, patient-specific data and machine learning, precision medicine. Founderof N of 1, acquired by Qiagen in 2019.

Lilly Wollman


A seasoned entrepreneurial leaderwith deep experience in strategy and operations, focused on commercial analytics, growth models and
high-performing culture development. Lilly is the former co-head of the Growth Equity Fund at Generation.

Order now or contact us to learn more